Careers At LifeScan
Join the LifeScan team. Find out more about career opportunities at LifeScan.
Read more >
The LifeScan Investigator-Initiated Study (IIS) Program encourages investigators to pursue and publish original diabetes-related research. LifeScan assists investigators by providing funds, products, or both to eligible studies.
How does the program work?
Investigators submit a study concept to LifeScan. If the concept is approved, investigators are asked to provide the study protocol and other details for additional review. Upon protocol approval, a contract is negotiated and signed. Investigators will receive funding, product, or both based on established milestones defined in the contract.
An IIS program study that has been supported is considered “completed” once the principal investigator (PI) submits a draft manuscript suitable for publication to LifeScan.
What is an investigator-initiated study?
An investigator-initiated study is a research effort in which the principal investigator (PI) not only designs and implements the study, but also acts as the study sponsor.
Although the word "sponsor" is commonly used to mean any kind of support, it has a specific meaning for scientific research. The sponsor is the individual (or entity) responsible for understanding and complying with any and all regulatory requirements related to the study. LifeScan cannot act as the sponsor for third-party research studies.
As a study sponsor, the PI is responsible for:
When research is being conducted by a group of investigators, it is preferable to have one principal investigator and several sub-investigators.
Under the IIS program, the PI is also responsible for: